Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. Its lead products candidate includes avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals Inc ( ($AMLX) ) has issued an announcement. On September 8, 2026, Amylyx Pharmaceuticals entered into a long‑term manufactur...

Amylyx inks long-term manufacturing deal for avexitide

LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Amylyx Pharmaceuticals Inc today and set a price target of $44.00. Katkhuda covers...

Amylyx Pharmaceuticals Inc (AMLX) Gets a Buy from LifeSci Capital

Amylyx Pharmaceuticals Inc ( ($AMLX) ) just unveiled an announcement. On August 19, 2026, Amylyx Pharmaceuticals Inc. entered into an underwriting ...

Amylyx Pharmaceuticals Announces Equity Offering to Fund Avexitide

According to a report in the Wall Street Journal, Costco ($COST) is about to launch its own Medicare Advantage plan in two states as part of a limi...

Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amylyx Pharmaceuticals Inc (AMLX), Moderna (MRNA) ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AMLX	$34.14	+4.63%	243.38K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AMLX	$34.14	+4.6%	243.38K
3
4
5
6

AMLX

Get Amylyx Pharmaceuticals, Inc. Data in Excel

Get Amylyx Pharmaceuticals, Inc. Data in Excel